Diagnostic yield and adverse events of liver biopsy in intensive-care-unit patients: a multicenter retrospective observational cohort study
In ICU patients, liver biopsy provides a wide range of diagnoses and guides treatment decisions. However, the risk of potentially fatal bleeding is a major concern. We identified risk factors for bleeding.
Authors
- Jean‐François Mosnier (ORCID: https://orcid.org/0000-0003-2637-3641)
- Lara Zafrani
- Marine Charrier (ORCID: https://orcid.org/0000-0003-2559-5621)
- Emmanuel Canet (ORCID: https://orcid.org/0000-0002-2143-8082)
- Jean-Claude Lachérade
- Jean Reignier
- Jean-Baptiste Lascarrou
- Jérôme Hoff
Institutions
- Université Paris Cité (FR)
- Saint Louis University Hospital (US)
- Centre Hospitalier Universitaire de Nantes (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpital Saint-Louis (FR)
- Centre Hospitalier Saint-Nazaire (FR)
- La Roche College (US)
- Nantes Université (FR)
Publication Details
- Journal
- Annals of Intensive Care
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1186/s13613-025-01533-0
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00